<DOC>
	<DOCNO>NCT00791895</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial investigate effectiveness biphasic insulin aspart 30 type 2 diabetic achieve blood sugar level treat oral anti-diabetics drug ( OADs ) without basal insulin therapy .</brief_summary>
	<brief_title>Efficacy Biphasic Insulin Aspart 30 Type 2 Diabetics Failing OADs</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes mellitus least 12 month HbA1c : 7.510.0 % An antidiabetic regimen stable least 3 month Able willing perform SMBG test per protocol Use insulin preparation NPH glargine within past 6 month Pregnancy , breastfeeding , intention become pregnant within next 12 month , judge use inadequate contraceptive measure ( adequate contraceptive measure include : sterilization , intrauterine device , oral contraceptive , consistent use barrier method ) Known suspect allergy trial product agent related trial product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>